Home/Pipeline/Starflu (Oseltamivir)

Starflu (Oseltamivir)

Influenza

MarketedActiveN/A

Key Facts

Indication

Influenza

Phase

Marketed

Status

Active

Company

Strides Pharma

About Strides Pharma

Strides Pharma Science Limited is a multinational pharmaceutical company with a mission to make quality healthcare accessible globally through a hybrid business model spanning regulated and emerging markets. Founded in 1990, it has evolved from a domestic Indian manufacturer into a global leader in complex generics and specialty pharmaceuticals, leveraging a vertically integrated structure with advanced manufacturing and R&D. Key achievements include a 5x increase in Q4 FY2025 net profit, a strategic 'In Africa, For Africa' initiative, and a robust portfolio of USFDA-approved facilities, positioning it for sustainable growth in the global generics market.

View full company profile

Therapeutic Areas

Infectious Diseases Oncology Autoimmune Diseases Central Nervous System Cardiovascular

Other Influenza Drugs

Drug	Company	Phase	Status
PanCytoVir™ (oral probenecid)	TrippBio	IND Submitted	Active
Influenza Antibodies	new/era/mabs	Research/Pre-clinical	Active
Influenza Countermeasure Program	DynPort Vaccines	Not Specified	Active
Influenza Vaccine	Medigen	Preclinical	Active
Nasal Influenza Vaccine	Abera Bioscience	Pre-clinical	Active
Zapnometinib (ATR-002)	Atriva Therapeutics	Phase 2	Active
EV25	Eradivir	Pre-clinical	Active
Not Specified	New Amsterdam Sciences	Pre-clinical	Active
Influenza Program	Arisan Therapeutics	Preclinical	Active
Universal Influenza Vaccine	Orlance	Pre-IND	Active
Enhanced Seasonal Influenza Vaccine	Orlance	Research	Active
Baloxavir marboxil (Xofluza®)	Shionogi	Marketed	Commercial (via Roche)